Pison Technology, Inc., a Boston, MA-based applications focused biopotential company, closed a $7M Series A round of funding.
The round was led by Lavrock Ventures, with participation from Bose Venture Capital, In-Q-Tel, and Decisive Point.
The company intends to use the funds to launch market ready products, with a series of ecosystem releases beginning in late 2021.
Founded in 2016 and led by Dexter Ang, CEO, Pison Technology is an applications focused biopotential company whose technology unlocks access to the physical and digital world by leveraging neurological insights, and its insights platform supports innovations in medicine, sports performance, and general wellness. The company captures neuromuscular signals on the surface of the skin and combines them with machine learning algorithms to enable the hands-free control of electronics. Using artificial intelligence, Pison interprets how people intend to move their hands and fingers, and transmits those signals to control digital devices, even before the desired motion is completed by the body.
The company has partnered in development with Google, Microsoft (Hololens), Mitsubishi Electric, Samsung, Boston Dynamics, and others.